| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,577 |
5,738 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
697 |
625 |
$13K |
| S9083 |
Global fee urgent care centers |
207 |
194 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
150 |
148 |
$6K |
| 90710 |
|
46 |
44 |
$6K |
| 90651 |
|
71 |
70 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
556 |
543 |
$4K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
210 |
210 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
32 |
32 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
216 |
216 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
562 |
549 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
15 |
14 |
$2K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
47 |
46 |
$2K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
15 |
13 |
$2K |
| 92552 |
|
390 |
390 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,924 |
1,856 |
$1K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$1K |
| 85018 |
|
681 |
680 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$1K |
| 3008F |
|
1,453 |
1,391 |
$928.85 |
| 99173 |
|
439 |
438 |
$855.12 |
| 81002 |
|
320 |
318 |
$837.88 |
| 80053 |
Comprehensive metabolic panel |
2,134 |
2,044 |
$802.12 |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14 |
14 |
$745.07 |
| 3074F |
|
1,859 |
1,748 |
$740.53 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
95 |
95 |
$734.78 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
18 |
12 |
$720.00 |
| 80061 |
Lipid panel |
1,838 |
1,825 |
$626.18 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
146 |
73 |
$618.35 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,563 |
2,234 |
$533.49 |
| 3078F |
|
2,838 |
2,609 |
$488.91 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
841 |
816 |
$381.00 |
| 92133 |
|
15 |
15 |
$278.17 |
| 92250 |
|
15 |
15 |
$271.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,358 |
1,351 |
$225.89 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
17 |
15 |
$196.80 |
| 3075F |
|
1,054 |
997 |
$180.23 |
| 92083 |
|
15 |
15 |
$156.03 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
43 |
28 |
$150.00 |
| 81000 |
|
237 |
237 |
$108.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,566 |
1,554 |
$99.48 |
| 90688 |
|
27 |
27 |
$98.14 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
59 |
59 |
$91.64 |
| 86580 |
|
33 |
33 |
$72.55 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
630 |
604 |
$68.56 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
175 |
174 |
$63.08 |
| 82962 |
|
101 |
94 |
$57.40 |
| 1159F |
|
90 |
88 |
$57.30 |
| 85730 |
|
61 |
38 |
$55.85 |
| 85610 |
|
57 |
38 |
$50.92 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
34 |
26 |
$50.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
228 |
228 |
$46.88 |
| 83690 |
|
13 |
12 |
$25.77 |
| 3079F |
|
216 |
213 |
$23.87 |
| 1160F |
|
88 |
87 |
$23.49 |
| 81001 |
|
695 |
675 |
$10.97 |
| 86592 |
|
762 |
758 |
$9.58 |
| 99401 |
|
249 |
249 |
$9.00 |
| 96150 |
|
250 |
250 |
$9.00 |
| 3077F |
|
274 |
265 |
$8.08 |
| 84439 |
|
103 |
103 |
$7.14 |
| 81003 |
|
464 |
463 |
$6.65 |
| 99000 |
|
163 |
158 |
$4.86 |
| 84550 |
|
509 |
509 |
$3.57 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
43 |
42 |
$1.42 |
| 90656 |
|
15 |
15 |
$1.00 |
| 82570 |
|
318 |
315 |
$0.00 |
| 84481 |
|
37 |
37 |
$0.00 |
| 97803 |
|
299 |
299 |
$0.00 |
| 3725F |
|
142 |
139 |
$0.00 |
| 94664 |
|
12 |
12 |
$0.00 |
| 83655 |
|
165 |
165 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
30 |
28 |
$0.00 |
| 90658 |
|
23 |
23 |
$0.00 |
| 82248 |
|
14 |
14 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
43 |
43 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
12 |
12 |
$0.00 |
| 90734 |
|
13 |
13 |
$0.00 |
| 82947 |
|
27 |
27 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
18 |
18 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$0.00 |
| 82043 |
|
298 |
298 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
92 |
91 |
$0.00 |
| 1036F |
|
119 |
116 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
249 |
249 |
$0.00 |
| 92499 |
|
181 |
181 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
95 |
95 |
$0.00 |
| 84436 |
|
603 |
603 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
277 |
264 |
$0.00 |
| 84479 |
|
431 |
431 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
144 |
143 |
$0.00 |
| 3080F |
|
12 |
12 |
$0.00 |
| 92551 |
|
210 |
210 |
$0.00 |
| 85027 |
|
104 |
103 |
$0.00 |
| 86803 |
|
12 |
12 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
250 |
250 |
$0.00 |
| 84480 |
|
105 |
105 |
$0.00 |
| 97802 |
|
12 |
12 |
$0.00 |
| 84153 |
|
25 |
24 |
$0.00 |